SCHEMBL28102855

SCHEMBL28102855

CC(C=O)c1cc(OCc2ccccc2)cc(N)c1O

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 2/20 0.44
▸ CYP1A1 P04798 1/20 0.44
▸ CYP19A1 P11511 1/20 0.44
▸ MEN1 O00255 1/20 0.43
▸ KMT2A Q03164 1/20 0.43
▸ MAOB P27338 5/20 0.41
▸ LMNA P02545 2/20 0.41
▸ PTGS1 P23219 1/20 0.41
▸ SLC6A2 P23975 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ SLC6A3 Q01959 1/20 0.41
▸ HIF1A Q16665 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ MAOA P21397 2/20 0.41
▸ LTA4H P09960 1/20 0.41
▸ L3MBTL1 Q9Y468 2/20 0.40
▸ ALOX5 P09917 1/20 0.40
▸ ERN1 O75460 1/20 0.40
▸ GAA P10253 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27664376 0.84 MEN1 (0.47) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL28147393 0.81 BACE1 (0.44) MEN1KMT2AMAOBMAOAL3MBTL1
SCHEMBL5193159 0.78 CYP1A2 (0.47) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL28769206 0.75 CYP1A2 (0.49) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL561095 0.74 MAOB (0.62) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL27761950 0.74 MAOB (0.48) MEN1KMT2AMAOBLMNAMAOA
SCHEMBL27577521 0.73 MAOB (0.47) MEN1KMT2AMAOBMAOAALOX5
SCHEMBL23638550 0.72 CYP1A2 (0.49) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL28849620 0.72 MAOB (0.49) CYP1A2CYP1A1CYP19A1MEN1KMT2A
SCHEMBL6188338 0.71 ALOX5 (0.55) CYP1A2MAOBLMNAPTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102827097-B The beta-2-agonists its preparation method of enantiomeric pure and the purposes in medicament forms thereof 贝林格尔英格海姆法玛两合公司 2016-11-23 — — CN disclosed
CN-106146425-A The beta-agonists its preparation method of new enantiomeric pure and the purposes in medicament forms thereof 贝林格尔英格海姆法玛两合公司 2016-11-23 — — CN disclosed
Send feedback